C07F 9 - Compounds containing elements of the 5th group of the periodic system

Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377)
11/2004
11/10/2004	EP1474380A2 4-dedimethylamino tetracycline compounds
11/10/2004	EP1474231A1 Oxidation catalyst and process for its preparation and process for oxidation using it
11/10/2004	EP1474177A2 Non-invasive diagnostic imaging technology for mitochondria using radiolabeled lipophilic salts
11/10/2004	EP1474128A2 S−DIMETHYLARSINO−THIOSUCCINIC ACID S−DIMETHYLARSINO−2−THIOBENZOIC ACID S−(DIMETHYLARSINO) GLUTATHIONE AS TREATMENTS FOR CANCER
11/10/2004	EP1240172B1 New aminopropylphosphinic acids
11/10/2004	EP1163051B1 Catalyst comprising a rhodium complex based on a phosphinamidite ligand and its use for hydroformylation
11/10/2004	CN1545643A Bathochromic mono-and bis-acylphosphine oxides and sulfides and their use as photoinitiators
11/10/2004	CN1545519A Flame retardant for polymeric materials
11/10/2004	CN1544440A Novel pulveres fosfomycin trometamol synthetic method
11/10/2004	CN1544439A High purity tributyl phosphate production method
11/10/2004	CN1174990C Catalyst component having at least phosphinimine ligand and heteroatom ligand
11/10/2004	CN1174989C Process for producing phosphorohalidate
11/10/2004	CN1174988C Technique of combination processing organic phosphorus and organosilicon monomer
11/10/2004	CN1174987C Prepn. of acetyl acetonyl copper with inserted lamellar vanadium phosphate
11/10/2004	CN1174955C 3-amino-2-benzyl-1-phenyl-propane derivs.
11/09/2004	US6815558 Process for preparing (metal) alkylphosphonites II
11/09/2004	CA2259559C Polymerization with living characteristics
11/08/2004	CA2466457A1 Process for producing phosphite
11/04/2004	WO2004094658A2 Fluorescent substrates for detecting organophosphatase enzyme activity
11/04/2004	WO2004094442A2 Asymmetric catalysts prepared from optically active bisphosphites bridged by achiral diols
11/04/2004	WO2004094441A2 Piperazine containing phosphonic acid compounds as inhibitors of serine proteases
11/04/2004	WO2004094440A2 Tertiary phosphines and their methods of preparation
11/04/2004	WO2004094439A2 Method for the production of acylphosphines
11/04/2004	WO2004094438A1 Phosphonium salts and methods of their preparation
11/04/2004	WO2004062596A3 Antineoplastic ether lipid compounds having a four carbon backbone
11/04/2004	US20040220663 Stent with variable stiffness
11/04/2004	US20040220422 Secondary phosphonate esters and alkene compounds are reacted in a transition metal medium; use as a carbon-carbon binding formation agent, as well as a synthesis intermediate for drugs and agrochemicals
11/04/2004	US20040220393 Modulation of HIF1alpha and HIF2alpha expression
11/04/2004	US20040220309 Novel phosphonium salt, organically modified layered silicate containing the phosphonium salt and composition thereof
11/04/2004	US20040220133 Composition and method for inhibiting platelet aggregation
11/04/2004	US20040219202 Pharmaceutical composition comprising lipids comprising a polar and a nonpolar moiety
11/04/2004	US20040219106 Compounds for use as surfactants
11/04/2004	US20040217005 Method for electroplating bath chemistry control
11/04/2004	DE102004013088A1 Phenolgruppe-enthaltende Phosphonitverbindung und Verfahren zur Herstellung Phenol group-containing phosphonite compound and processes for preparing
11/03/2004	EP1473349A2 Organic electroluminescent devices, aminostyrylnaphthalene compounds and synthesis intermediates thereof, and production processes of the same
11/03/2004	EP1473297A1 Process for producing tertiary phosphine having bulky hydrocarbon group bonded
11/03/2004	EP1472909A1 Electroluminescent iridium compounds with phosphinoalkoxides and phenylpyridines or phenylpyrimidines and devices made with such compounds
11/03/2004	EP1472536A2 Broad spectrum inhibitors
11/03/2004	EP1472260A2 Thieno(3,2-b)pyridones as antiviral compounds
11/03/2004	EP1472230A2 Ansamycins having improved pharmacological and biological properties
11/03/2004	EP1472217A2 Method for producing perfluoroalkane sulfonic acid esters and the salts thereof
11/03/2004	EP1472201A2 Method for the separation of acids from chemical reaction mixtures by means of ionic fluids
11/03/2004	EP1472188A1 Purification of onium hydroxides by electrodialysis
11/03/2004	EP1471921A2 Counteracting bioprosthetic calcification
11/03/2004	EP1471920A2 Process for preparing water-soluble phosphonooxymethyl derivatives of alcohol and phenol
11/03/2004	EP1471870A2 Use of lipid conjugates in the treatment of disease
11/03/2004	EP1456176A4 Improved compounds for generating chemiluminescence with a peroxidase
11/03/2004	EP1305278B1 Ruthenium complexes and their use in asymmetric hydrogenation
11/03/2004	EP1019353B1 Improved metal-ligand complex catalyzed processes
11/03/2004	EP0956021B1 L-beta-dioxolane uridine analogs for treating and preventing infections by ebv, vzv and hv-8
11/03/2004	CN1543470A Novel phosphite compounds and novel phosphite metal complexes
11/03/2004	CN1543469A Novel phosphite compounds and the metal complexes thereof
11/03/2004	CN1173985C Novel diphenylarsines
11/03/2004	CN1173984C Method of purifying thiamine phosphates
11/03/2004	CN1173983C Process for preparing phosphonium
11/03/2004	CN1173982C Sulphur-containing organic compound modified metal-chalocogenide nm particles, its prepn. and application
11/03/2004	CN1173954C Compounds, compositions and methods for generating chemiluminescence with phosphatase enzymes
11/03/2004	CN1173946C Method for preparing an N-[(aliphatic or aromatic) carbonyl]-2-aminoacetamide compound and a cyclyzed compound
11/03/2004	CN1173914C Improved separation processes
11/03/2004	CN1173913C Method of using easy removed nitroxyl selective alcohol axide
11/02/2004	US6812365 Disulfone reagents and methods of preparing and using same
11/02/2004	US6812352 Multidentate phosphite ligands, catalytic compositions containing such ligands, and catalytic processes utilizing such catalytic compositions
11/02/2004	US6812306 Metallic compounds and the use thereof in the polymerization of olefins
11/02/2004	US6812240 8-azaprostaglandin carbonate and thiocarbonate analogs as therapeutic agents
11/02/2004	US6812231 Inhibiting activated blood-coagulation factor x
11/02/2004	US6812227 Acetylenic α-amino acid-based sulfonamide hydroxamic acid tace inhibitors
11/02/2004	US6812224 Phosphorous organic compounds and their use
11/02/2004	CA2103454C Macrocyclic immunomodulators
10/2004
10/28/2004	WO2004092707A2 Aromatic phosphonium salts and their use as labeling reagents mass spectrometry analysis
10/28/2004	WO2004092225A1 Supported metallocene catalysts
10/28/2004	WO2004092190A1 Catalyst and process for preparation of termoelastoplastic polyolefins
10/28/2004	WO2004092189A1 Derivatives of 2-(8,9-dioxo-2,6-diazabicyclo(5.2.0)non-1(7)-en-2-yl)alkyl phosphonic acid and their use as n-methyl-d-aspartate (nmda) recetor antagonists
10/28/2004	WO2004092188A2 Analogs of lysophosphatidic acid and methods of making and using thereof
10/28/2004	WO2004092187A1 Phosphate derivatives
10/28/2004	WO2004092186A1 Phosphates of secondary alcohols
10/28/2004	WO2004092139A2 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto
10/28/2004	WO2004091780A1 Process for the preparation of a nickel/phosphorous ligand catalyst
10/28/2004	WO2004091636A1 Phosphate derivatives of pharmaceutical products
10/28/2004	WO2004078100A3 A poymerizable phosphoric acid ester derivative and a dental composition employing it.
10/28/2004	WO2004071442A3 Novel bicyclic compounds and compositions
10/28/2004	WO2004043359B1 N-oxides and derivatives of melphalan for treating diseased states associated with hypoxia inducible factor
10/28/2004	WO2004004648A3 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
10/28/2004	US20040215028 Combining a terminal alkyne with a first transition metal complex to give a second transition metal complex; treating the second transition metal complex with a base
10/28/2004	US20040215027 Locates chirality closer to the metal center than known metal phospholane complexes; provides high enantiomeric excesses
10/28/2004	US20040214887 for example, 6,9-Dihydroxy-2,2,13,13-tetramethyl-tetradecanedioic acid, 2,2,13,13-Tetramethyl-tetradecane-1,6,9,14-tetraol, 6,10-Dihydroxy-2,2,14,14-tetramethyl-pentadecanedioic acid; treatment of Alzheimer's Disease, metabolic syndrome disorder, cancer, cardiovascular disease, diabetic nephropathy
10/28/2004	US20040214874 Inhibition of protein-tyrosine kinase cmet to block cancer cell proliferation, oral bioavailibility; 2-(2,6-dichlorophenyl)-4-phenyl-5-(pyrimidin-4yl)-1H-imidazoles
10/28/2004	US20040214869 2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia
10/28/2004	US20040214801 9-Substituted minocycline compounds
10/28/2004	US20040214799 for suppression of cancer cell invasion and cancer metastasis
10/28/2004	US20040214798 Nitroaryl phosphoramide compositions and methods for targeting and inhibiting undesirable cell growth or proliferation
10/28/2004	US20040213836 DRUG DELIVERY; prolonging the time a pharmaceutical drug circulates in the blood of a subject, comprising: introducing into the subject's bloodstream a pharmaceutical composition comprising a liposome containing inventive compound
10/28/2004	CA2521842A1 Phosphate derivatives of pharmaceutical products
10/28/2004	CA2521837A1 Phosphate derivatives
10/28/2004	CA2521836A1 Phosphates of secondary alcohols
10/28/2004	CA2521652A1 Supported metallocene catalysts
10/28/2004	CA2521313A1 Derivatives of 2-(8,9-dioxo-2,6-diazabicyclo(5.2.o)non-1(7)-3n-2-yl)-al kyl phosphonic acid and their use as n-methyl-d-aspartate (nmda) recetor antagonists
10/27/2004	EP1471054A1 Amino alcohol derivative or phosphonic acid derivative and medicinal composition containing these
10/27/2004	EP1471036A1 IM-8 type cristalline metallophosphate solid and process for its preparation
10/27/2004	EP1470138A1 Mmp inhibitors
10/27/2004	EP1470137A1 Edg receptor agonists

1 ... 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 ... 554